Works in Cancer Chemotherapy & Pharmacology, 2014, Vol 73, Issue 1

Results: 29

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.

Published in:

2014

By:

Harmon, Charles S;
Deprimo, Samuel E;
Figlin, Robert A;
Hudes, Gary R;
Hutson, Thomas E;
Michaelson, M Dror;
Négrier, Sylvie;
Kim, Sindy T;
Huang, Xin;
Williams, J Andrew;
Eisen, Tim;
Motzer, Robert J

Publication type:

journal article

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 151, doi. 10.1007/s00280-013-2333-4

By:

Harmon, Charles;
DePrimo, Samuel;
Figlin, Robert;
Hudes, Gary;
Hutson, Thomas;
Michaelson, M.;
Négrier, Sylvie;
Kim, Sindy;
Huang, Xin;
Williams, J.;
Eisen, Tim;
Motzer, Robert

Publication type:

Article

The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 199, doi. 10.1007/s00280-013-2341-4

By:

Yang, Chih-Jen;
Tsai, Ying-Ming;
Tsai, Ming-Ju;
Chang, Hsu-Liang;
Huang, Ming-Shyan

Publication type:

Article

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 213, doi. 10.1007/s00280-013-2351-2

By:

Chiu, Yi-Lin;
LoRusso, Patricia;
Hosmane, Balakrishna;
Ricker, Justin;
Awni, Walid;
Carlson, Dawn

Publication type:

Article

A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma.

Published in:

2014

By:

Grippo, J F;
Zhang, W;
Heinzmann, D;
Yang, K H;
Wong, J;
Joe, A K;
Munster, P;
Sarapa, N;
Daud, A

Publication type:

journal article

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)

Published in:

2014

By:

Kang, Yoon-Koo;
Yook, Jeong Hwan;
Chang, Heung-Moon;
Ryu, Min-Hee;
Yoo, Changhoon;
Zang, Dae Young;
Lee, Jae-Lyun;
Kim, Tae Won;
Yang, Dae Hyun;
Jang, Se Jin;
Park, Young Soo;
Lee, Young Jack;
Jung, Hwoon-Yong;
Kim, Jin-Ho;
Kim, Byung Sik

Publication type:

Journal Article

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 43, doi. 10.1007/s00280-013-2315-6

By:

Jakobsen, Jan;
Santoni-Rugiu, Eric;
Sørensen, Jens

Publication type:

Article

A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)

Published in:

2014

By:

Hattori, Yoshihiro;
Satouchi, Miyako;
Katakami, Nobuyuki;
Fujita, Shiro;
Kaji, Reiko;
Hata, Akito;
Urata, Yoshiko;
Shimada, Temiko;
Uchida, Junji;
Tomii, Keisuke;
Morita, Satoshi;
Negoro, Shunichi

Publication type:

Journal Article

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 163, doi. 10.1007/s00280-013-2334-3

By:

Kim, Young;
Sym, Sun;
Park, Se;
Park, Inkeun;
Hong, Junshik;
Ahn, Hee;
Park, Jinny;
Cho, Eun;
Lee, Woon;
Chung, Min;
Lee, Jae;
Shin, Dong

Publication type:

Article

Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 87, doi. 10.1007/s00280-013-2322-7

By:

Wit, D.;
Gelderblom, H.;
Sparreboom, A.;
Hartigh, J.;
Hollander, M.;
König-Quartel, J.;
Hessing, T.;
Guchelaar, H.;
Erp, N.

Publication type:

Article

Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 125, doi. 10.1007/s00280-013-2328-1

By:

Hong, Jung;
Nam, Eun;
Lee, Jeeyun;
Park, Joon;
Lee, Sang-Cheol;
Song, Seo-Young;
Choi, Seong;
Heo, Jin;
Park, Se;
Lim, Ho;
Kang, Won;
Park, Young

Publication type:

Article

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 113, doi. 10.1007/s00280-013-2327-2

By:

Joerger, M.;
Huitema, A.;
Koeberle, D.;
Rosing, H.;
Beijnen, J.;
Hitz, F.;
Cerny, T.;
Schellens, J.;
Gillessen, S.

Publication type:

Article

Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 207, doi. 10.1007/s00280-013-2337-0

By:

Tawbi, Hussein;
Christner, Susan;
Lin, Yan;
Johnson, Matthew;
Mowrey, Emily;
Cherrin, Craig;
Chu, Edward;
Lee, James;
Puhalla, Shannon;
Stoller, Ronald;
Appleman, Leonard;
Miller, Brian;
Beumer, Jan

Publication type:

Article

Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 9, doi. 10.1007/s00280-013-2264-0

By:

Cho, Eun;
Park, Ji-Young;
Lee, Kyung;
Song, Hong;
Min, Young;
Kim, Yeul;
Kang, Jin-Hyoung

Publication type:

Article

Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 97, doi. 10.1007/s00280-013-2323-6

By:

Yamaue, Hiroki;
Satoi, Sohei;
Kanbe, Takamasa;
Miyazawa, Motoki;
Tani, Masaji;
Kawai, Manabu;
Hirono, Seiko;
Okada, Kenichi;
Yanagimoto, Hiroaki;
Kwon, A-Hon;
Mukouyama, Tomoyuki;
Tsunoda, Hiroaki;
Chijiiwa, Kazuo;
Ohuchida, Jiro;
Kato, Jun;
Ueda, Kazuki;
Yamaguchi, Taketo;
Egawa, Shinichi;
Hayashi, Kazuhiko;
Shirasaka, Tetsuhiko

Publication type:

Article

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 139, doi. 10.1007/s00280-013-2332-5

By:

Kang, Yoon-Koo;
Yook, Jeong;
Chang, Heung-Moon;
Ryu, Min-Hee;
Yoo, Changhoon;
Zang, Dae;
Lee, Jae-Lyun;
Kim, Tae;
Yang, Dae;
Jang, Se;
Park, Young;
Lee, Young;
Jung, Hwoon-Yong;
Kim, Jin-Ho;
Kim, Byung

Publication type:

Article

E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 171, doi. 10.1007/s00280-013-2338-z

By:

Owonikoko, Taofeek;
Aisner, Joseph;
Wang, Xin;
Dahlberg, Suzanne;
Rubin, Eric;
Ramalingam, Suresh;
Gounder, Murugesan;
Rausch, Paul;
Axelrod, Rita;
Schiller, Joan

Publication type:

Article

Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 191, doi. 10.1007/s00280-013-2340-5

By:

Yi, Seung;
Kang, Dae;
Kim, Kyung;
Park, Mi;
Seong, Jinsil;
Park, Jeong;
Bang, Seung;
Song, Si;
Chung, Jae;
Park, Seung

Publication type:

Article

Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 25, doi. 10.1007/s00280-013-2304-9

By:

Park, Hue;
Stokes, Jennifer;
Corr, Maripat;
Yaksh, Tony

Publication type:

Article

A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF mutation-positive metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 103, doi. 10.1007/s00280-013-2324-5

By:

Grippo, J.;
Zhang, W.;
Heinzmann, D.;
Yang, K.;
Wong, J.;
Joe, A.;
Munster, P.;
Sarapa, N.;
Daud, A.

Publication type:

Article

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 35, doi. 10.1007/s00280-013-2314-7

By:

Thomas, Sheeba;
Suvorov, Alexander;
Noens, Lucien;
Rukavitsin, Oleg;
Fay, Joseph;
Wu, Ka;
Zimmerman, Todd;
Velde, Helgi;
Bandekar, Rajesh;
Puchalski, Thomas;
Qi, Ming;
Uhlar, Clarissa;
Samoylova, Olga

Publication type:

Article

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 181, doi. 10.1007/s00280-013-2339-y

By:

Molina, Ana;
Hutson, Thomas;
Larkin, James;
Gold, Anne;
Wood, Karen;
Carter, Dave;
Motzer, Robert;
Michaelson, M.

Publication type:

Article

Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 61, doi. 10.1007/s00280-013-2317-4

By:

Floquet, Anne;
Doussau, Adélaïde;
Brouste, Véronique;
Cany, Laurent;
Dutin, Jean-Philippe;
Mathoulin-Pélissier, Simone

Publication type:

Article

Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 53, doi. 10.1007/s00280-013-2316-5

By:

Ando, Hitoshi;
Natsume, Atsushi;
Senga, Takeshi;
Watanabe, Reiko;
Ito, Ichiro;
Ohno, Masasuke;
Iwami, Kenichiro;
Ohka, Fumiharu;
Motomura, Kazuya;
Kinjo, Sayano;
Ito, Maki;
Saito, Kiyoshi;
Morgan, Richard;
Wakabayashi, Toshishiko

Publication type:

Article

Mechanisms of action of tasquinimod on the tumour microenvironment.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 1, doi. 10.1007/s00280-013-2321-8

By:

Raymond, E.;
Dalgleish, A.;
Damber, J.-E.;
Smith, M.;
Pili, R.

Publication type:

Article

Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 69, doi. 10.1007/s00280-013-2318-3

By:

Gong, Lei;
Yang, Bo;
Xu, Ming;
Cheng, Bo;
Tang, Xuejun;
Zheng, Ping;
Jing, Yan;
Wu, Gao-jue

Publication type:

Article

A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001).

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 17, doi. 10.1007/s00280-013-2290-y

By:

Hattori, Yoshihiro;
Satouchi, Miyako;
Katakami, Nobuyuki;
Fujita, Shiro;
Kaji, Reiko;
Hata, Akito;
Urata, Yoshiko;
Shimada, Temiko;
Uchida, Junji;
Tomii, Keisuke;
Morita, Satoshi;
Negoro, Shunichi

Publication type:

Article

Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 131, doi. 10.1007/s00280-013-2329-0

By:

Jakobsen, Jan;
Santoni-Rugiu, Eric;
Sørensen, Jens

Publication type:

Article

Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 79, doi. 10.1007/s00280-013-2319-2

By:

Xu, Wei-qun;
Zhang, Ling-yan;
Chen, Xue-ying;
Pan, Bin-hua;
Mao, Jun-qing;
Song, Hua;
Li, Jing-yuang;
Tang, Yong-min

Publication type:

Article